EP0537232A4 - Recombinant pigeon pox virus vaccine - Google Patents

Recombinant pigeon pox virus vaccine

Info

Publication number
EP0537232A4
EP0537232A4 EP19910912297 EP91912297A EP0537232A4 EP 0537232 A4 EP0537232 A4 EP 0537232A4 EP 19910912297 EP19910912297 EP 19910912297 EP 91912297 A EP91912297 A EP 91912297A EP 0537232 A4 EP0537232 A4 EP 0537232A4
Authority
EP
European Patent Office
Prior art keywords
virus vaccine
pox virus
pigeon pox
recombinant
recombinant pigeon
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP19910912297
Other versions
EP0537232A1 (en
Inventor
Guy Meulemans
Carine Letellier
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline Beecham Corp
Original Assignee
SmithKline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SmithKline Beecham Corp filed Critical SmithKline Beecham Corp
Publication of EP0537232A1 publication Critical patent/EP0537232A1/en
Publication of EP0537232A4 publication Critical patent/EP0537232A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86Viral vectors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011Details
    • C12N2710/24011Poxviridae
    • C12N2710/24111Orthopoxvirus, e.g. vaccinia virus, variola
    • C12N2710/24141Use of virus, viral particle or viral elements as a vector
    • C12N2710/24143Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011Details
    • C12N2760/18011Paramyxoviridae
    • C12N2760/18111Avulavirus, e.g. Newcastle disease virus
    • C12N2760/18122New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Plant Pathology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
EP19910912297 1990-07-02 1991-07-01 Recombinant pigeon pox virus vaccine Withdrawn EP0537232A4 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US54747090A 1990-07-02 1990-07-02
US547470 1990-07-02

Publications (2)

Publication Number Publication Date
EP0537232A1 EP0537232A1 (en) 1993-04-21
EP0537232A4 true EP0537232A4 (en) 1993-06-30

Family

ID=24184753

Family Applications (1)

Application Number Title Priority Date Filing Date
EP19910912297 Withdrawn EP0537232A4 (en) 1990-07-02 1991-07-01 Recombinant pigeon pox virus vaccine

Country Status (6)

Country Link
EP (1) EP0537232A4 (en)
JP (1) JPH05508540A (en)
KR (1) KR930701588A (en)
AU (1) AU8213391A (en)
CA (1) CA2084064A1 (en)
WO (1) WO1992000372A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993025666A1 (en) * 1992-06-16 1993-12-23 Commonwealth Scientific And Industrial Research Organisation Recombinant entomopoxvirus
JPH08116976A (en) * 1994-10-20 1996-05-14 Chemo Sero Therapeut Res Inst Nucleic acid preparation for immunization and immunizing method using the acid
US6241991B1 (en) 1998-03-05 2001-06-05 Akzo Nobel N.V. Aviadenovirus
CN107630036A (en) * 2017-10-16 2018-01-26 佛山科学技术学院 A kind of Muscovy duck parvovirus VP1 genetic recombination pigeon avipoxvirus transfer vector

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0308220A1 (en) * 1987-09-16 1989-03-22 Nippon Zeon Co., Ltd. Recombinant avipoxvirus
EP0404576A2 (en) * 1989-06-22 1990-12-27 Nippon Zeon Co., Ltd. Recombinant avipoxvirus
EP0419666A1 (en) * 1988-12-29 1991-04-03 Nippon Zeon Co., Ltd. Promoter, plasmid containing the same, and recombinant avipoxvirus

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3429965A (en) * 1966-08-01 1969-02-25 Sterling Drug Inc Avian pox virus vaccine and process of preparing same
WO1988002022A1 (en) * 1986-09-22 1988-03-24 Commonwealth Scientific And Industrial Research Or Recombinant poxviruses

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0308220A1 (en) * 1987-09-16 1989-03-22 Nippon Zeon Co., Ltd. Recombinant avipoxvirus
EP0419666A1 (en) * 1988-12-29 1991-04-03 Nippon Zeon Co., Ltd. Promoter, plasmid containing the same, and recombinant avipoxvirus
EP0404576A2 (en) * 1989-06-22 1990-12-27 Nippon Zeon Co., Ltd. Recombinant avipoxvirus

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
ARCHIVES OF VIROLOGY vol. 118, no. 1-2, 1991, WIEN, AUSTRIA pages 43 - 56 LETELLIER, C. ET AL. 'Construction of a pigeonpox virus recombinant: expresiion of the Newcastle disease virus (NDV9 fusion glycoprotein and protection of chickens against NDV challenge' *
See also references of WO9200372A1 *

Also Published As

Publication number Publication date
WO1992000372A1 (en) 1992-01-09
AU8213391A (en) 1992-01-23
JPH05508540A (en) 1993-12-02
KR930701588A (en) 1993-06-12
CA2084064A1 (en) 1992-01-03
EP0537232A1 (en) 1993-04-21

Similar Documents

Publication Publication Date Title
GB2246784B (en) Herpes virus recombinant poxvirus vaccine
GB9303023D0 (en) Flavivirus recombinant poxvirus vaccine
GB2245272B (en) Recombinant virus selection system
AU2371692A (en) Recombinant hepatitis a virus vaccine
EP0717636A4 (en) Malaria recombinant poxvirus vaccine
DE69016956T2 (en) Recombinant turkey herpes virus and derived live vaccine vector.
HU912526D0 (en) Recombinant marek-type disease virus
FR2620459B1 (en) RECOMBINANT VACCINE VIRUS
HUP9601466A2 (en) Adjuvants for viral vaccines
ZA924150B (en) Vaccine for human immunodeficiency virus
GB2264949B (en) Measles virus recombinant poxvirus vaccine
HUP9601462A2 (en) Adjuvants for viral vaccines
AU1257092A (en) Interferon sensitive recombinant poxvirus vaccine
HU9300010D0 (en) Glycoprotein vaccine named ehv-4
AU5679394A (en) Hepatitis b virus vaccines
EP0537232A4 (en) Recombinant pigeon pox virus vaccine
EP0575544A4 (en) Malaria recombinant poxvirus vaccine
EP0598759A4 (en) Recombinant infectious bovine rhinotracheitis virus.
AU2347692A (en) Recombinant viral vaccine
ZA908189B (en) Infectious bronchitis virus vaccine
HU9203976D0 (en) Vaccine based on modified herpes virus
AU2775692A (en) Recombinant influenza virus vaccine compositions
ZA919198B (en) Measles virus recombinant poxvirus vaccine
AU6051396A (en) Measles virus recombinant poxvirus vaccine
GB9109763D0 (en) Herpes virus vaccine

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 19921210

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH DE DK ES FR GB GR IT LI LU NL SE

RHK1 Main classification (correction)

Ipc: C12N 15/86

A4 Supplementary search report drawn up and despatched

Effective date: 19930511

AK Designated contracting states

Kind code of ref document: A4

Designated state(s): AT BE CH DE DK ES FR GB GR IT LI LU NL SE

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 19950201